RTTNews | Sep 1, 2021 11:10AM EDT

11:09 Wednesday, September 1, 2021 (RTTNews.com) - ABVC BioPharma, Inc. (ABVC) shares are trading more than 30 percent on Wednesday morning after the company announced new patent cooperation treaty or PCT application to treat major depressive disorder or MDD and Attention-Deficit Hyperactivity Disorder or ADHD.The applications are for oral administration of compositions containing Radix Polygalae extract or PDC-1421 for both the MDD and ADHD drugs.

Currently, shares are at $3.77, up 30.00 percent from the previous close of $2.90 on a volume of 45,565,707. The shares have traded in a range of $1.95-$8.00 on average volume of 587,269.

Read the original article on RTTNews ( https://www.rttnews.com/3222632/abvc-biopharma-spikes-30-on-two-pct-application-for-mdd-adhd.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved